Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.

Identifieur interne : 001B14 ( Main/Exploration ); précédent : 001B13; suivant : 001B15

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.

Auteurs : Xingxing Yang [République populaire de Chine] ; Xiaojuan Chen [République populaire de Chine] ; Guangxing Bian [République populaire de Chine] ; Jian Tu [Australie] ; Yaling Xing [République populaire de Chine] ; Yayun Wang [République populaire de Chine] ; Zhongbin Chen [République populaire de Chine]

Source :

RBID : pubmed:24362959

Descripteurs français

English descriptors

Abstract

The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pulmonary disease in humans and represents the second example of a highly pathogenic coronavirus (CoV) following severe acute respiratory syndrome coronavirus (SARS-CoV). Genomic studies revealed that two viral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), process the polyproteins encoded by the MERS-CoV genomic RNA. We previously reported that SARS-CoV PLpro acts as both deubiquitinase (DUB) and IFN antagonist, but the function of the MERS-CoV PLpro was poorly understood. In this study, we characterized MERS-CoV PLpro, which is a protease and can recognize and process the cleavage sites (CS) of nsp1-2, nsp2-3 and nsp3-4. The LXGG consensus cleavage sites in the N terminus of pp1a/1ab, which is generally essential for CoV PLpro-mediated processing, were also characterized in MERS-CoV. MERS-CoV PLpro, like human SARS-CoV PLpro and NL63-CoV PLP2, is a viral deubiquitinating enzyme. It acts on both K48- and K63-linked ubiquitination and ISG15-linked ISGylation. We confirmed that MERS-CoV PLpro acts as an IFN antagonist through blocking the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3). These findings indicate that MERS-CoV PLpro acts as a viral DUB and suppresses production of IFN-β by an interfering IRF3-mediated signalling pathway, in addition to recognizing and processing the CS at the N terminus of replicase polyprotein to release the non-structural proteins. The characterization of proteolytic processing, DUB and IFN antagonist activities of MERS-CoV PLpro would reveal the interactions between MERS-CoV and its host, and be applicable to develop strategies targeting PLpro for the effective control of MERS-CoV infection.

DOI: 10.1099/vir.0.059014-0
PubMed: 24362959


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.</title>
<author>
<name sortKey="Yang, Xingxing" sort="Yang, Xingxing" uniqKey="Yang X" first="Xingxing" last="Yang">Xingxing Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Anhui Medical University, Hefei, Anhui Province 230032, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Anhui Medical University, Hefei, Anhui Province 230032</wicri:regionArea>
<wicri:noRegion>Anhui Province 230032</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Xiaojuan" sort="Chen, Xiaojuan" uniqKey="Chen X" first="Xiaojuan" last="Chen">Xiaojuan Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bian, Guangxing" sort="Bian, Guangxing" uniqKey="Bian G" first="Guangxing" last="Bian">Guangxing Bian</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tu, Jian" sort="Tu, Jian" uniqKey="Tu J" first="Jian" last="Tu">Jian Tu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109</wicri:regionArea>
<wicri:noRegion>NSW 2109</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xing, Yaling" sort="Xing, Yaling" uniqKey="Xing Y" first="Yaling" last="Xing">Yaling Xing</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wang, Yayun" sort="Wang, Yayun" uniqKey="Wang Y" first="Yayun" last="Wang">Yayun Wang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Zhongbin" sort="Chen, Zhongbin" uniqKey="Chen Z" first="Zhongbin" last="Chen">Zhongbin Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Anhui Medical University, Hefei, Anhui Province 230032, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Anhui Medical University, Hefei, Anhui Province 230032</wicri:regionArea>
<wicri:noRegion>Anhui Province 230032</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24362959</idno>
<idno type="pmid">24362959</idno>
<idno type="doi">10.1099/vir.0.059014-0</idno>
<idno type="wicri:Area/PubMed/Corpus">001B05</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B05</idno>
<idno type="wicri:Area/PubMed/Curation">001B05</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B05</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001771</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001771</idno>
<idno type="wicri:Area/Ncbi/Merge">000C37</idno>
<idno type="wicri:Area/Ncbi/Curation">000C37</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C37</idno>
<idno type="wicri:Area/Main/Merge">001B23</idno>
<idno type="wicri:Area/Main/Curation">001B14</idno>
<idno type="wicri:Area/Main/Exploration">001B14</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.</title>
<author>
<name sortKey="Yang, Xingxing" sort="Yang, Xingxing" uniqKey="Yang X" first="Xingxing" last="Yang">Xingxing Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Anhui Medical University, Hefei, Anhui Province 230032, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Anhui Medical University, Hefei, Anhui Province 230032</wicri:regionArea>
<wicri:noRegion>Anhui Province 230032</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Xiaojuan" sort="Chen, Xiaojuan" uniqKey="Chen X" first="Xiaojuan" last="Chen">Xiaojuan Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bian, Guangxing" sort="Bian, Guangxing" uniqKey="Bian G" first="Guangxing" last="Bian">Guangxing Bian</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tu, Jian" sort="Tu, Jian" uniqKey="Tu J" first="Jian" last="Tu">Jian Tu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109</wicri:regionArea>
<wicri:noRegion>NSW 2109</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xing, Yaling" sort="Xing, Yaling" uniqKey="Xing Y" first="Yaling" last="Xing">Yaling Xing</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wang, Yayun" sort="Wang, Yayun" uniqKey="Wang Y" first="Yayun" last="Wang">Yayun Wang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infection and Immunity, Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100850</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Zhongbin" sort="Chen, Zhongbin" uniqKey="Chen Z" first="Zhongbin" last="Chen">Zhongbin Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Anhui Medical University, Hefei, Anhui Province 230032, PR China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Anhui Medical University, Hefei, Anhui Province 230032</wicri:regionArea>
<wicri:noRegion>Anhui Province 230032</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of general virology</title>
<idno type="eISSN">1465-2099</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>Coronaviridae (chemistry)</term>
<term>Coronaviridae (enzymology)</term>
<term>Coronaviridae (genetics)</term>
<term>Coronaviridae Infections (metabolism)</term>
<term>Coronaviridae Infections (virology)</term>
<term>Humans</term>
<term>Interferon Regulatory Factor-3 (metabolism)</term>
<term>Interferon-beta (antagonists & inhibitors)</term>
<term>Interferon-beta (metabolism)</term>
<term>Molecular Sequence Data</term>
<term>Papain (chemistry)</term>
<term>Papain (genetics)</term>
<term>Papain (metabolism)</term>
<term>Phosphorylation</term>
<term>Polyproteins (genetics)</term>
<term>Polyproteins (metabolism)</term>
<term>Protein Processing, Post-Translational</term>
<term>Proteolysis</term>
<term>Sequence Alignment</term>
<term>Ubiquitin</term>
<term>Ubiquitin-Specific Proteases (chemistry)</term>
<term>Ubiquitin-Specific Proteases (genetics)</term>
<term>Ubiquitin-Specific Proteases (metabolism)</term>
<term>Viral Proteins (chemistry)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alignement de séquences</term>
<term>Coronaviridae ()</term>
<term>Coronaviridae (enzymologie)</term>
<term>Coronaviridae (génétique)</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Facteur-3 de régulation d'interféron (métabolisme)</term>
<term>Humains</term>
<term>Infections à Coronaviridae (métabolisme)</term>
<term>Infections à Coronaviridae (virologie)</term>
<term>Interféron bêta (antagonistes et inhibiteurs)</term>
<term>Interféron bêta (métabolisme)</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Papaïne ()</term>
<term>Papaïne (génétique)</term>
<term>Papaïne (métabolisme)</term>
<term>Phosphorylation</term>
<term>Polyprotéines (génétique)</term>
<term>Polyprotéines (métabolisme)</term>
<term>Protéines virales ()</term>
<term>Protéines virales (génétique)</term>
<term>Protéines virales (métabolisme)</term>
<term>Protéolyse</term>
<term>Séquence d'acides aminés</term>
<term>Ubiquitin-specific proteases ()</term>
<term>Ubiquitin-specific proteases (génétique)</term>
<term>Ubiquitin-specific proteases (métabolisme)</term>
<term>Ubiquitine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Interferon-beta</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Papain</term>
<term>Ubiquitin-Specific Proteases</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Papain</term>
<term>Polyproteins</term>
<term>Ubiquitin-Specific Proteases</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Interferon Regulatory Factor-3</term>
<term>Interferon-beta</term>
<term>Papain</term>
<term>Polyproteins</term>
<term>Ubiquitin-Specific Proteases</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Interféron bêta</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Coronaviridae</term>
<term>Papaïne</term>
<term>Polyprotéines</term>
<term>Protéines virales</term>
<term>Ubiquitin-specific proteases</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Coronaviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Facteur-3 de régulation d'interféron</term>
<term>Infections à Coronaviridae</term>
<term>Interféron bêta</term>
<term>Papaïne</term>
<term>Polyprotéines</term>
<term>Protéines virales</term>
<term>Ubiquitin-specific proteases</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronaviridae Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>Phosphorylation</term>
<term>Protein Processing, Post-Translational</term>
<term>Proteolysis</term>
<term>Sequence Alignment</term>
<term>Ubiquitin</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Alignement de séquences</term>
<term>Coronaviridae</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Papaïne</term>
<term>Phosphorylation</term>
<term>Protéines virales</term>
<term>Protéolyse</term>
<term>Séquence d'acides aminés</term>
<term>Ubiquitin-specific proteases</term>
<term>Ubiquitine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pulmonary disease in humans and represents the second example of a highly pathogenic coronavirus (CoV) following severe acute respiratory syndrome coronavirus (SARS-CoV). Genomic studies revealed that two viral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), process the polyproteins encoded by the MERS-CoV genomic RNA. We previously reported that SARS-CoV PLpro acts as both deubiquitinase (DUB) and IFN antagonist, but the function of the MERS-CoV PLpro was poorly understood. In this study, we characterized MERS-CoV PLpro, which is a protease and can recognize and process the cleavage sites (CS) of nsp1-2, nsp2-3 and nsp3-4. The LXGG consensus cleavage sites in the N terminus of pp1a/1ab, which is generally essential for CoV PLpro-mediated processing, were also characterized in MERS-CoV. MERS-CoV PLpro, like human SARS-CoV PLpro and NL63-CoV PLP2, is a viral deubiquitinating enzyme. It acts on both K48- and K63-linked ubiquitination and ISG15-linked ISGylation. We confirmed that MERS-CoV PLpro acts as an IFN antagonist through blocking the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3). These findings indicate that MERS-CoV PLpro acts as a viral DUB and suppresses production of IFN-β by an interfering IRF3-mediated signalling pathway, in addition to recognizing and processing the CS at the N terminus of replicase polyprotein to release the non-structural proteins. The characterization of proteolytic processing, DUB and IFN antagonist activities of MERS-CoV PLpro would reveal the interactions between MERS-CoV and its host, and be applicable to develop strategies targeting PLpro for the effective control of MERS-CoV infection. </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Yang, Xingxing" sort="Yang, Xingxing" uniqKey="Yang X" first="Xingxing" last="Yang">Xingxing Yang</name>
</noRegion>
<name sortKey="Bian, Guangxing" sort="Bian, Guangxing" uniqKey="Bian G" first="Guangxing" last="Bian">Guangxing Bian</name>
<name sortKey="Chen, Xiaojuan" sort="Chen, Xiaojuan" uniqKey="Chen X" first="Xiaojuan" last="Chen">Xiaojuan Chen</name>
<name sortKey="Chen, Zhongbin" sort="Chen, Zhongbin" uniqKey="Chen Z" first="Zhongbin" last="Chen">Zhongbin Chen</name>
<name sortKey="Wang, Yayun" sort="Wang, Yayun" uniqKey="Wang Y" first="Yayun" last="Wang">Yayun Wang</name>
<name sortKey="Xing, Yaling" sort="Xing, Yaling" uniqKey="Xing Y" first="Yaling" last="Xing">Yaling Xing</name>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Tu, Jian" sort="Tu, Jian" uniqKey="Tu J" first="Jian" last="Tu">Jian Tu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B14 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B14 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24362959
   |texte=   Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24362959" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021